You are here

cell therapy

Novo Nordisk Foundation to establish €127 million cell therapy plant

Novo Nordisk Foundation to establish €127 million cell therapy plant

Biopharma Reporter

Flag link:

Cell therapy developer closes funding round to support diabetes program

Cell therapy developer closes funding round to support diabetes program

BioPharma Dive

Flag link:

Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe

Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe

Reuters

Oxford BioMedica

Flag link:

FDA capacity forces delay to Iovance's cell therapy

FDA capacity forces delay to Iovance's cell therapy

Pharmaphorum

Iovance Biotherapeutics

Flag link:

BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure

BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure

BioSpace

clinical trials

Flag link:

Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval

Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval

Fierce Biotech

executive compensation

Flag link:

Notch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle offices

Notch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle offices

Geekwire

Notch Therapeutics

Flag link:

Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data

Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data

MedCity News

Parkinson's Disease

clinical trials

Flag link:

Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study

Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study

Fierce Biotech

Parkinson's Disease

BlueRock Therapeutics

Flag link:

Aspen taps tech firms for digital Parkinson's trial

Aspen taps tech firms for digital Parkinson's trial

Pharmaphorum

Apen Neuroscience

Parkinson's Disease

Emerald Innovations

Flag link:

BMS backs $255m round for contract cell maker Cellares

BMS backs $255m round for contract cell maker Cellares

Pharmaphorum

Bristol Myers Squibb

Flag link:

FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death

FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death

Fierce Biotech

Gilead Sciences

Flag link:

Thermo Fisher lays off 200-plus at clinical-stage cell and gene therapy factory in Florida

Thermo Fisher lays off 200-plus at clinical-stage cell and gene therapy factory in Florida

Fierce Pharma

ThermoFisher Scientific

Flag link:

FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data

FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data

BioSpace

graft vs host disease

Flag link:

Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center

Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center

Fierce Biotech

Vertex Pharmaceuticals

Flag link:

FDA rejects Mesoblast's cell therapy for bone marrow transplant complications

FDA rejects Mesoblast's cell therapy for bone marrow transplant complications

Yahoo/Reuters

bone marrow transplants

Flag link:

3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond

3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond

Motley Fool

Caribou Biosciences

relapsed or refractory B cell lymphoma

Flag link:

Kincell spins out of a cell therapy biotech, joining wave of manufacturing startups

Kincell spins out of a cell therapy biotech, joining wave of manufacturing startups

BioPharma Dive

Flag link:

This 1 Innovation Could Make These 2 Biotechs Soar by 2030

This 1 Innovation Could Make These 2 Biotechs Soar by 2030

Motley Fool

Caribou Biosciences

CRISPR Therapeutics

Flag link:

Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise

Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise

BioPharma Dive

Turnstone Biologics

Flag link:

Pages